Wiltrom Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 01, 2023
Share
Wiltrom Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 75.22 million compared to TWD 58.28 million a year ago. Net loss was TWD 10.12 million compared to net income of TWD 2.46 million a year ago. Basic loss per share from continuing operations was TWD 0.35 compared to basic earnings per share from continuing operations of TWD 0.08 a year ago. Diluted loss per share from continuing operations was TWD 0.35 compared to diluted earnings per share from continuing operations of TWD 0.08 a year ago.
For the nine months, sales was TWD 210.54 million compared to TWD 152.98 million a year ago. Net income was TWD 8.54 million compared to net loss of TWD 11.79 million a year ago. Basic earnings per share from continuing operations was TWD 0.29 compared to basic loss per share from continuing operations of TWD 0.41 a year ago. Diluted earnings per share from continuing operations was TWD 0.29 compared to diluted loss per share from continuing operations of TWD 0.41 a year ago.
Wiltrom Co., Ltd. is a Taiwan-based company mainly engaged in the development, manufacture and sale of spinal fusion surgery products. The main products are spinal fixators, artificial bones and interbody fusion cages. The Company's products are mainly focused on three parts including spinal fusion surgery related products, spinal compression fracture surgery products and bone cement products. The Company distributes its products mainly in Taiwan, Asia, America and other places.
WILTROM CO., LTD. 
